Transforming Growth Factor-Beta in Cancer Therapy, Volume I
Basic and Clinical Biology
(Sprache: Englisch)
Transforming Growth Factor- ß in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ß (TGF- ß) in cancer treatment and therapy. The first volume, Basic and Clinical Biology, is divided into three...
Leider schon ausverkauft
versandkostenfrei
Buch
235.39 €
Produktdetails
Produktinformationen zu „Transforming Growth Factor-Beta in Cancer Therapy, Volume I “
Klappentext zu „Transforming Growth Factor-Beta in Cancer Therapy, Volume I “
Transforming Growth Factor- ß in Cancer Therapy, Vols. 1 and 2, provides a compendium of findings about the role of transforming growth factor- ß (TGF- ß) in cancer treatment and therapy. The first volume, Basic and Clinical Biology, is divided into three parts. This volume's companion, Cancer Treatment in Therapy, examines transforming growth factor- ß in other developing and advanced cancers and methods of treatment and therapy.
Inhaltsverzeichnis zu „Transforming Growth Factor-Beta in Cancer Therapy, Volume I “
- Component Hardware for Transforming Growth Factor-ß Signal Transduction: TGF-ß Ligands, TGF-ß Receptors, and Smads- TGF-ß Signaling in Homeostasis and Cancer
- TGF-ß Availability: Latent TGF-ß and Latent TGF-ß Binding Proteins
- Biological Functions of Latent TGF-ß Binding Proteins and Activation of TGF-ß
- Regulators of Smad2/3 Transcription and Phosphorylation
- Interaction of Smad4 and Embryonic Liver Fodrin (ELF)-ß-spectrin in Hyperplasia, Neoplasia, and Tumor Progression
- Regulation of Smad Activity by Phosphorylation
- Nuclear Targeting of TGF-ß-activated Smads in Normal and Tumor Biology
- Ski, Sno and Akt as Negative Regulators of Smad Activity: Balancing Cell Death and Cell Survival
- Smurfs in TGF-ß Signaling and Regulation of Bone Homeostasis and Cancer
- Involvement of KM23 Dynein Light Chains in TGF-ß Signaling
- TGF-ß Signaling in Fibroblastic Cells and Oncogenes
- Mechanisms of TGF-ß-induced Apoptosis in Cancer Cells
- Mechanisms of Cell Cycle Regulation by TGF-ß Disabled in Cancer
- Proteasome in the Control of TGF-ß Signaling During Development and Cancer
- TGF-ß and Smad Signaling in Transcriptome Reprogramming During Epithelial to Mesenchymal Transition
- Functional Interaction between MMPs and TGF-ß in Normal and Tumor Tissue
- Cooperation Between TGF-ß and Wnt Pathway Components in Regulating Mesenchymal Stem Cell Function
- Interaction of Oncogenic Ras and TGF-ß1 Signaling in Cancer: Lessons from the Multistage Skin Carcinogenesis Model
- Proteomics Analysis of TGFß Superfamily Members
- Mullerian Inhibiting Substance: A Potential Nontoxic, Naturally Occurring Therapeutic Agent for Certain Human Cancers
- Activins, Inhibins and Bone Morphogenetic Proteins as Modulators of Prostate Cancer Progression
- Bone Morphogenic Proteins and Angiogenesis in Developing Tumors
- Histone Methyltransferase and Smad Interactions in BMP Signaling
- Endoglin (CD105): A Strong Candidate for Immunologic Targeting of Tumor Neovasculature
... mehr
in HumanMalignancies
- Activins and Inhibins in Cancer Progression
- Bone Morphogenetic Proteins/Growth Differentiation Factors and Smad Activation in Granulosa Cells and Carcinoma
- Regulation of the TGF-ß Superfamily by Betaglycan
- Uterine Sensitization Associated Gene-1 (USAG): A Bone Morphogenic Protein Antagonist with a Role in Kidney
- Role of Betaig-h3 Gene in Carcinogenesis
- Activins and the Liver
- Myostatin Signaling in Normal and Tumor Cells
- Triterpenoids, Vitamin D, and TGF-ß/Smad Signaling in Inflammation and Cancer
- Thrombospondin-dependent Activation of Latent TGF-ß in Fibrosis and Disease
- TGF-ß1 in Pulmonary Fibrosis
- The Role of TGF-beta in Bleomycin Induced Pulmonary Fibrosis
- Smads in the Fibrotic Response: Findings in the Smad3 Knockout Mouse
- TGF-ß Signaling in Renal Fibrosis and Inflammation: Gene Therapy using Ultrasound-Microbubble-mediated Inducible Smad7
- Transforming Growth Facator-ß Peptide Signaling in Pulmonary Development, Bronchopulmonary Dysplasia, Fibrosis, and Emphysema
- The Role of TGF-ß in Radiation and Chemotherapy Induced Pulmonary Fibrosis: Inhibition of TGF-ß as a Novel Therapeutic Strategy
- Negative Regulation of the TGF-ßFamily Signaling Pathway by Inhibitory Smads and Their Involvement in Cancer and Fibrosis
- TGF-ß-Related Antifibrotic Strategies in the Eye
- TGF-ß in Cutaneous Tissue Repair
- Topical Application of TGF-ß1 Peptide Inhibitors for the Therapy of Skin Fibrosis
- Overexpressed Truncated TGF-ß Type II Receptor Inhibits Fibrotic Behavior of Keloid Fibroblasts In Vitro and Experimental Scar Formation In Vivo
- Activins and Inhibins in Cancer Progression
- Bone Morphogenetic Proteins/Growth Differentiation Factors and Smad Activation in Granulosa Cells and Carcinoma
- Regulation of the TGF-ß Superfamily by Betaglycan
- Uterine Sensitization Associated Gene-1 (USAG): A Bone Morphogenic Protein Antagonist with a Role in Kidney
- Role of Betaig-h3 Gene in Carcinogenesis
- Activins and the Liver
- Myostatin Signaling in Normal and Tumor Cells
- Triterpenoids, Vitamin D, and TGF-ß/Smad Signaling in Inflammation and Cancer
- Thrombospondin-dependent Activation of Latent TGF-ß in Fibrosis and Disease
- TGF-ß1 in Pulmonary Fibrosis
- The Role of TGF-beta in Bleomycin Induced Pulmonary Fibrosis
- Smads in the Fibrotic Response: Findings in the Smad3 Knockout Mouse
- TGF-ß Signaling in Renal Fibrosis and Inflammation: Gene Therapy using Ultrasound-Microbubble-mediated Inducible Smad7
- Transforming Growth Facator-ß Peptide Signaling in Pulmonary Development, Bronchopulmonary Dysplasia, Fibrosis, and Emphysema
- The Role of TGF-ß in Radiation and Chemotherapy Induced Pulmonary Fibrosis: Inhibition of TGF-ß as a Novel Therapeutic Strategy
- Negative Regulation of the TGF-ßFamily Signaling Pathway by Inhibitory Smads and Their Involvement in Cancer and Fibrosis
- TGF-ß-Related Antifibrotic Strategies in the Eye
- TGF-ß in Cutaneous Tissue Repair
- Topical Application of TGF-ß1 Peptide Inhibitors for the Therapy of Skin Fibrosis
- Overexpressed Truncated TGF-ß Type II Receptor Inhibits Fibrotic Behavior of Keloid Fibroblasts In Vitro and Experimental Scar Formation In Vivo
... weniger
Bibliographische Angaben
- 2008, 2008, 735 Seiten, Maße: 18,3 x 26 cm, Gebunden, Englisch
- Herausgegeben:Jakowlew, Sonia B.;Mitarbeit:Sporn, M.B.
- Herausgegeben: Sonia B. Jakowlew
- Verlag: Humana Press
- ISBN-10: 1588297144
- ISBN-13: 9781588297143
- Erscheinungsdatum: 28.02.2008
Sprache:
Englisch
Rezension zu „Transforming Growth Factor-Beta in Cancer Therapy, Volume I “
From the reviews:"This volume provides a comprehensive review of TGF-beta regulation, signaling, and cellular function in both normal and tumor biology. ... will be of use to individuals interested in the role of TGF-beta in the development of cancer and fibrosis. This will likely benefit readers interested in TGF-beta in the pathogenesis of disease ... . also be a resource for those interested in the complex intracellular signaling cascades elicited by TGF-beta in normal and altered cells." (James P Luyendyk, Doody's Review Service, May, 2008)
Kommentar zu "Transforming Growth Factor-Beta in Cancer Therapy, Volume I"
0 Gebrauchte Artikel zu „Transforming Growth Factor-Beta in Cancer Therapy, Volume I“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Transforming Growth Factor-Beta in Cancer Therapy, Volume I".
Kommentar verfassen